FundamentalVR, a VR surgical simulation software provider, has raised USD 20 million in a Series B funding round led by EQT Life Sciences with participation from Downing Ventures. As a result of the investment, Drew Burdon (partner, EQT) will join the company’s board.
The fresh funds were earmarked for its expansion across the US and product development initiatives.
<ul><li> Analyst QuickTake : The round follows a USD 66 million Series C raise by its competitor Osso VR. While FundamentalVR is planning to expand to the US market (its operational presence so far has been in the UK), Osso VR already has a presence in over 20 countries. FundamentalVR differentiates its solution by incorporating a patented haptic system (“HapticVR”) that delivers users the full sense of force-feedback touch, enabling procedural rehearsal in deep simulation with precise measurements. This will be key in pursuing market share in competitive markets such as the US.</ul>
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.